home / stock / cmnd / cmnd articles

CMND Articles, Caleminder Inc

Stock Information
Company Name: Caleminder Inc
Stock Symbol: CMND
Market: OTC
Menu
CMND CMND Quote CMND Short CMND News CMND Articles CMND Message Board
Get CMND Alerts

News, Short Squeeze, Breakout and More Instantly...
Why Psychedelic-Pharma Clearmind Medicine Stock Is Moving Higher | Benzinga

Clearmind Medicine Inc. (NASDAQ:CMND) shares are trading higher Friday after the company announced advancement in its proprietary MEAI-based binge ...
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment | Benzinga

Vancouver, Canada, June 28, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), ...

What's Going On With Clearmind Medicine Stock Tuesday? | Benzinga

Clearmind Medicine Inc (NASDAQ:CMND) on Tuesday announced advancement in its proprietary MEAI-based alcohol substitute beverage program. What Happe...

Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product | Benzinga

The global market of no- and low-alcohol beverages estimated at over $13 billion in 2023 Vancouver, Canada, May 10, 2024 (GLOBE NEWSWIRE) -- Cle...
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adj...

Why Clearmind Medicine Stock Is Moving Higher | Benzinga

Clearmind Medicine Inc. (NASDAQ:CMND) shares are up Tuesday after the company announced it signed an exclusive patent licensing agreement with Yiss...

Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment | Benzinga

Vancouver, Canada, May 07, 2024 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"),...
Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders | Benzinga

Vancouver, Canada, April 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "company")...

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More | Benzinga

Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024. See prev...

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year ...
Next 10